SCHEMBL715575

SCHEMBL715575

CC/C=C/CC(O)CCCC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 4/20 0.62
FFAR4 Q5NUL3 3/20 0.62
NFKB1 P19838 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55
FPR2 P25090 1/20 0.51
ALDH1A1 P00352 6/20 0.50
CYP19A1 P11511 4/20 0.50
OXER1 Q8TDS5 4/20 0.50
F7 P08709 3/20 0.50
F3 P13726 3/20 0.50
PPARG P37231 3/20 0.50
PTGS1 P23219 3/20 0.50
KMT2A Q03164 2/20 0.50
PPARD Q03181 2/20 0.50
PPARA Q07869 2/20 0.50
RXRA P19793 2/20 0.50
ADORA3 P0DMS8 1/20 0.50
MAPT P10636 3/20 0.47
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL715576 1.00 FFAR1 (0.62) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL9221303 1.00 FFAR1 (0.62) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL11403989 0.95 FFAR1 (0.69) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL31524891 0.93 FFAR1 (0.72) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL31524744 0.93 FFAR1 (0.72) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL31524655 0.93 FFAR1 (0.72) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL31524749 0.93 FFAR1 (0.72) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL31524642 0.93 FFAR1 (0.72) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL30197038 0.93 FFAR1 (0.72) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL30197353 0.93 FFAR1 (0.72) FFAR1FFAR4NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US claimed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP claimed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO claimed
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US disclosed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
CN-117304151-A Novel synthesis method of jasmine lactone 安徽华业香料合肥有限公司 2023-12-29 CN disclosed
CN-117137809-A Wet tissue package and chemical liquid for wet tissue 尤妮佳股份有限公司 2023-12-01 CN disclosed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 US disclosed
EP-3368542-B1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2022-06-22 EP disclosed
WO-2017075257-A2 HIGH INTENSITY SWEETENERS SENOMYX, INC. (US) 2017-05-04 WO disclosed
US-20170096418-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2017-04-06 US disclosed
US-20170087199-A1 COMPOSITIONS FOR DELIVERING A COOLING SENSATION SENOMYX INC (US) 2017-03-30 US disclosed
US-20170057940-A1 SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME P2 SCIENCE, INC. 2017-03-02 US disclosed
US-20160376263-A1 BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF SENOMYX INC (US) 2016-12-29 US disclosed
EP-3107904-A1 SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME P2 Science, Inc. (US) 2016-12-28 EP disclosed
WO-2015126936-A1 SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME P2 SCIENCE, INC. (US) 2015-08-27 WO disclosed
US-20120053133-A1 ANTISEPTIC AGENT COMPOSITION TAIYO CORPORATION (JP) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 FFAR1 1804/4885FFAR4 2363/4885NFKB1 2617/4885
US-20160376263-A1 BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF TAS2R5, TAS1R1, TAS2R1 FFAR1 228/4885FFAR4 171/4885NFKB1 3249/4885
US-20170057940-A1 SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME FASN, EBP, LSS FFAR1 99/4885FFAR4 105/4885NFKB1 1473/4885
US-20170087199-A1 COMPOSITIONS FOR DELIVERING A COOLING SENSATION TRPA1, PDE6G, PDE6D FFAR1 282/4885FFAR4 216/4885NFKB1 993/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 FFAR1 1804/4885FFAR4 2363/4885NFKB1 2617/4885
US-20170096418-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM6, TRPM4 FFAR1 1242/4885FFAR4 1230/4885NFKB1 2375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.